Abstract:Introduction: Coronary microvascular dysfunction (CMD) is characterized by impaired endothelial-dependent vasodilation. These impairments are seen in diabetic cardiomyopathy, ischemia with no obstructive coronary artery disease, and heart failure with preserved ejection fraction (HFpEF), but detailed mechanisms have yet to be elucidated. Sirtuin 6 (Sirt6), an important member of the Sirtuin family, has been implicated in obesity, insulin resistance, type 2 diabetes mellitus (T2DM), and cardiovascular diseases. Sirt6 protects EC from premature senescence, oxidative stress, and atherosclerosis by sustaining high eNOS levels and preserving cell replication. Sirt6 was reported to regulate endothelial dilation in atherosclerosis in Sirt6 heterozygous mice, but how Sirt6 regulates coronary microvascular function remains to be determined. Methods: Sirt6 knockout and wild-type (WT) mice were fed a diet high in fat and sugar (HFHS) for six months, and blood lipid and glucose were measured. Coronary arteries were isolated, and endothelial-dependent vasodilation (EDD) was assessed using myography (DMT). Echocardiography and treadmill exercise exertion tests were performed to evaluate cardiac function. Myocardial blood flow (MBF) was measured by doppler. Cardiac fibrosis was detected using trichrome staining, and molecular pathways were elucidated via gene and protein analysis. Results: Our preliminary data show that Sirt6 was downregulated in diabetes. The EDD of coronary arterioles was impaired, and the mediator of coronary vasodilation switched from NO to H 2 O 2 in the Sirt6 knockout mice. Compared to the WT mice, myocardial blood flow is decreased, ejection fraction (EF) was not changed, the running distance was reduced, and E/E’ ratio was increased in Sirt6 knockout mice. The Sirt6 targeted proteins were identified. Conclusions: Sirt6 regulated coronary microvascular function, and ablation of Sirt6 caused CMD and diastolic dysfunction. Further genetic profiling will elucidate the pathways and mechanisms converging with Sirt6 to regulate microvascular function.

SIRT6: A potential therapeutic target for diabetic cardiomyopathy

SIRT6 Suppresses Mitochondrial Defects and Cell Death Via the NF-κB Pathway in Myocardial Hypoxia/reoxygenation Induced Injury.

Sirtuin 6: A Potential Therapeutic Target for Cardiovascular Diseases.

SIRT6's function in controlling the metabolism of lipids and glucose in diabetic nephropathy

The Role of Mammalian Sirtuin 6 in Cardiovascular Diseases and Diabetes Mellitus

SIRT6 in Regulation of Mitochondrial Damage and Associated Cardiac Dysfunctions: A Possible Therapeutic Target for CVDs

SIRT6 Mitigates Heart Failure With Preserved Ejection Fraction in Diabetes

Sirt6-Mediated Endothelial-To-Mesenchymal Transition Contributes Toward Diabetic Cardiomyopathy Via The Notch1 Signaling Pathway

Abstract P3138: The Regulatory Role Of Sirtuin 6 In Coronary Microvascular Dysfunction

Sirt5 improves cardiomyocytes fatty acid metabolism and ameliorates cardiac lipotoxicity in diabetic cardiomyopathy via CPT2 de-succinylation

Cardioprotective Effects of SIRT6 in a Mouse Model of Transverse Aortic Constriction-Induced Heart Failure.

Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence

SIRT6 activates PPARα to improve doxorubicin-induced myocardial cell aging and damage

SIRT6 Protects Against Endothelial Dysfunction and Atherosclerosis in Mice

SIRT6 Regulates Metabolic Homeostasis in Skeletal Muscle Through Activation of AMPK.

SIRT6 Regulates Obesity-Induced Oxidative Stress Via ENDOG/SOD2 Signaling in the Heart.

SIRT1-FOXOs signaling pathway: A potential target for attenuating cardiomyopathy

SIRT1 Activation by Resveratrol Alleviates Cardiac Dysfunction Via Mitochondrial Regulation in Diabetic Cardiomyopathy Mice.

SIRT6 in Senescence and Aging-Related Cardiovascular Diseases

SIRT6 in Aging, Metabolism, Inflammation and Cardiovascular Diseases

Melatonin attenuates diabetic cardiomyopathy and reduces myocardial vulnerability to ischemia‐reperfusion injury by improving mitochondrial quality control: Role of SIRT6